Lee T L, Fung F M, Chen F G, Chou N, Okuda-Ashitaka E, Ito S, Nishiuchi Y, Kimura T, Tachibana S
Department of Anaesthesia, National University of Singapore.
Neuroreport. 1999 May 14;10(7):1537-41. doi: 10.1097/00001756-199905140-00026.
Nocistatin was recently isolated from bovine brain and shown to block hyperalgesia and allodynia induced by nociceptin and prostaglandin (PG) E2. The counterparts of human, rat and mouse are deduced from their precursor prepronociceptin to be 30, 35, and 41 residue peptide respectively. To identify these mature forms of nocistatin, three peptides were synthesized and a detection program for nocistatin was developed, using high pressure liquid chromatography (HPLC) along with specific radioimmunoassay (RIA). Nocistatin extracted from human, rat and mouse brain were subjected to HPLC and nocistatin-like immunoreactivity (NST-IR) was determined. All three species showed two NST-IR peaks, one of which coincided with that of the corresponding putative nocistatin. The same NST-IR was also detected in human cerebrospinal fluid (CSF).
痛稳素最近从牛脑中分离出来,被证明能阻断痛敏肽和前列腺素(PG)E2诱导的痛觉过敏和异常性疼痛。根据人前体前痛敏肽推断,人、大鼠和小鼠的痛稳素分别为30、35和41个残基的肽。为了鉴定这些痛稳素的成熟形式,合成了三种肽,并开发了一种痛稳素检测程序,采用高压液相色谱(HPLC)和特异性放射免疫分析(RIA)。从人、大鼠和小鼠脑中提取的痛稳素进行HPLC分析,并测定痛稳素样免疫反应性(NST-IR)。所有三个物种都显示出两个NST-IR峰,其中一个与相应的假定痛稳素峰一致。在人脑脊液(CSF)中也检测到相同的NST-IR。